- Home
- UBCP vs CMRX Comparison
UBCP vs CMRX Comparison
Compare UBCP & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBCP
- CMRX
- Stock Information
- Founded
- UBCP 1902
- CMRX 2000
- Country
- UBCP United States
- CMRX United States
- Employees
- UBCP N/A
- CMRX N/A
- Industry
- UBCP Major Banks
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- UBCP Finance
- CMRX Health Care
- Exchange
- UBCP Nasdaq
- CMRX Nasdaq
- Market Cap
- UBCP 77.3M
- CMRX 77.1M
- IPO Year
- UBCP N/A
- CMRX 2013
- Fundamental
- Price
- UBCP $12.84
- CMRX $0.86
- Analyst Decision
- UBCP
- CMRX Strong Buy
- Analyst Count
- UBCP 0
- CMRX 1
- Target Price
- UBCP N/A
- CMRX $11.00
- AVG Volume (30 Days)
- UBCP 6.9K
- CMRX 282.9K
- Earning Date
- UBCP 11-06-2024
- CMRX 11-07-2024
- Dividend Yield
- UBCP 5.54%
- CMRX N/A
- EPS Growth
- UBCP N/A
- CMRX N/A
- EPS
- UBCP 1.36
- CMRX N/A
- Revenue
- UBCP $29,229,619.00
- CMRX $159,000.00
- Revenue This Year
- UBCP N/A
- CMRX $1,772.84
- Revenue Next Year
- UBCP $8.94
- CMRX N/A
- P/E Ratio
- UBCP $9.42
- CMRX N/A
- Revenue Growth
- UBCP N/A
- CMRX N/A
- 52 Week Low
- UBCP $10.38
- CMRX $0.75
- 52 Week High
- UBCP $15.50
- CMRX $1.30
- Technical
- Relative Strength Index (RSI)
- UBCP 48.94
- CMRX 41.07
- Support Level
- UBCP $12.03
- CMRX $0.91
- Resistance Level
- UBCP $13.05
- CMRX $1.12
- Average True Range (ATR)
- UBCP 0.39
- CMRX 0.09
- MACD
- UBCP -0.05
- CMRX -0.01
- Stochastic Oscillator
- UBCP 59.44
- CMRX 10.31
About UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. The company's primary deposit products are checking, savings and term certificate accounts and its primary lending products are residential mortgages, commercial and installment loans. The company serves customers mainly located in Athens, Belmont, Carroll, Fairfield, Harrison, Jefferson and Tuscarawas Counties in Ohio and Marshall and Ohio Counties in West Virginia and the surrounding localities in northeastern, east-central and southeastern Ohio and include a wide range of individuals, businesses and other organizations.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.